Regarding the other markers individually, p53 IHC revealed that only 11.1% of cases of mucinous carcinoma had overexpressed p53, compared to 34.1% of cases of serous carcinoma, which showed overexpression in 45.5% of cases. The gene discussed is TP53; the disease is serous adenocarcinoma.